These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 3698014

  • 1. In vitro and in vivo radiation sensitization by the halogenated pyrimidine 5-chloro-2'-deoxycytidine.
    Russell KJ, Rice GC, Brown JM.
    Cancer Res; 1986 Jun; 46(6):2883-7. PubMed ID: 3698014
    [Abstract] [Full Text] [Related]

  • 2. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA, Boothman DA, Perez LM, Greer S.
    Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
    [Abstract] [Full Text] [Related]

  • 3. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
    Boothman DA, Briggle TV, Greer S.
    Cancer Res; 1987 May 01; 47(9):2344-53. PubMed ID: 2436761
    [Abstract] [Full Text] [Related]

  • 4. Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA, Boothman DA, Greer SB.
    Cancer Res; 1985 Nov 01; 45(11 Pt 1):5270-80. PubMed ID: 2932216
    [Abstract] [Full Text] [Related]

  • 5. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA, Briggle TV, Greer S.
    Cancer Res; 1987 May 01; 47(9):2354-62. PubMed ID: 2952263
    [Abstract] [Full Text] [Related]

  • 6. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine.
    Doiron A, Yapp DT, Olivares M, Zhu JX, Lehnert S.
    Cancer Res; 1999 Aug 01; 59(15):3677-81. PubMed ID: 10446981
    [Abstract] [Full Text] [Related]

  • 7. Reversal of deamination-related cytotoxicity of 5-methyl-2'-deoxycytidine by tetrahydrouridine in human leukemia cells.
    Jekunen A, Vilpo JA.
    J Natl Cancer Inst; 1984 Nov 01; 73(5):1087-91. PubMed ID: 6593484
    [Abstract] [Full Text] [Related]

  • 8. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
    Lawrence TS, Davis MA, Maybaum J, Mukhopadhyay SK, Stetson PL, Normolle DP, McKeever PE, Ensminger WD.
    Cancer Res; 1992 Jul 01; 52(13):3698-704. PubMed ID: 1617642
    [Abstract] [Full Text] [Related]

  • 9. Sensitization to X ray by 5-chloro-2'-deoxycytidine co-administered with tetrahydrouridine in several mammalian cell lines and studies of 2'-chloro derivatives.
    Perez LM, Greer S.
    Int J Radiat Oncol Biol Phys; 1986 Aug 01; 12(8):1523-7. PubMed ID: 3759575
    [Abstract] [Full Text] [Related]

  • 10. Thermal sensitivity and radiosensitization in V79 cells after BrdUrd or IdUrd incorporation.
    Raaphorst GP, Vadasz JA, Azzam EI.
    Radiat Res; 1984 Apr 01; 98(1):167-75. PubMed ID: 6718691
    [Abstract] [Full Text] [Related]

  • 11. Modification of potentially lethal damage in irradiated Chinese hamster V79 cells after incorporation of halogenated pyrimidines.
    Franken NA, Van Bree CV, Kipp JB, Barendsen GW.
    Int J Radiat Biol; 1997 Jul 01; 72(1):101-9. PubMed ID: 9246199
    [Abstract] [Full Text] [Related]

  • 12. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE, Davis TW, Schupp JE, Hwang HS, de Wind N, Kinsella TJ.
    Cancer Res; 2000 Oct 15; 60(20):5773-80. PubMed ID: 11059773
    [Abstract] [Full Text] [Related]

  • 13. In vitro transformation by bromodeoxyuridine and X irradiation in C3H 10T1/2 cells.
    Raaphorst GP, Azzam EI, Borsa J, Sargent MD.
    Radiat Res; 1985 Feb 15; 101(2):279-91. PubMed ID: 3975357
    [Abstract] [Full Text] [Related]

  • 14. The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
    Lawrence TS, Davis MA, Maybaum J, Stetson PL, Ensminger WD.
    Radiat Res; 1990 Aug 15; 123(2):192-8. PubMed ID: 2389005
    [Abstract] [Full Text] [Related]

  • 15. Ataxia telangiectasia cells exhibit the same radiosensitization response by incorporation of BrdUrd or IdUrd as do normal human cells.
    Raaphorst GP, Azzam EI, Vadasz JA.
    Radiat Res; 1985 Sep 15; 103(3):455-60. PubMed ID: 4034938
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Marked radiosensitization of cells in culture to X ray by 5-chlorodeoxycytidine coadministered with tetrahydrouridine, and inhibitors of pyrimidine biosynthesis.
    Perez LM, Mekras JA, Briggle TV, Greer S.
    Int J Radiat Oncol Biol Phys; 1984 Aug 15; 10(8):1453-8. PubMed ID: 6236189
    [Abstract] [Full Text] [Related]

  • 20. Selective radiosensitization and cytotoxicity of human melanoma cells using halogenated deoxycytidines and tetrahydrouridine.
    Lawrence TS, Davis MA.
    Int J Radiat Oncol Biol Phys; 1989 May 15; 16(5):1243-6. PubMed ID: 2715074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.